npj Precision Oncology (Запис № 459913)
[ простий вигляд ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 03995nas a22004455i 4500 |
| 001 - CONTROL NUMBER | |
| control field | 2397-768X |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | DE-He213 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20240830153219.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr nn 008mamaa |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 160623s||||||||xxkuu poo|||||| b|EN |d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 2397-768X |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1038/41698.2397-768X |
| Source of number or code | doi |
| 210 10 - ABBREVIATED TITLE | |
| Abbreviated title | npj Precis. Onc. |
| 245 10 - TITLE STATEMENT | |
| Title | npj Precision Oncology |
| Medium | [electronic resource] / |
| Statement of responsibility, etc | edited by Collin M Blakely, Jakob Kather, Trever Bivona, Zigang Dong, Ann M. Bode, Collin M Blakely, Jakob Kather. |
| 264 #1 - | |
| -- | London : |
| -- | Nature Publishing Group UK : |
| -- | Imprint: Nature Portfolio. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Other physical details | online resource. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc | npj Precision Oncology considers research covering all aspects of basic science, translational, and clinical research in the field of precision oncology. The journal broadly defines precision oncology as cancer diagnosis, prognosis, prevention, and treatment tailored specifically to the individual patient based on the genetic and/or molecular profile of the patient. We welcome innovative, well-conducted, and deep studies. The journal covers a broad range of topics including but not limited to: Targeted therapy and precision medicine clinical trials and therapeutic strategies Biomarker studies that include both biological and external validation using an independent cohort Immunotherapies, immune checkpoint inhibitors, adoptive cell therapies, cancer vaccines, and immunomodulatory agents for personalized cancer treatment Applications of liquid biopsy techniques, including circulating tumor DNA, circulating tumor cells, and exosomes, for non-invasive cancer detection, monitoring, and treatment response assessment Tumor heterogeneity, clonal evolution, and tumor microenvironment dynamics in cancer progression, metastasis, and therapy resistance Genomic profiling and molecular characterization of cancer Drug resistance mechanisms and therapeutic strategies Clinical applications of predictive modeling, artificial intelligence, and computational oncology, including studies on large language models for research applications or clinical applications in oncology; and studies on deep learning-based data analysis in oncology with external validation and clear clinical potential Pharmacogenomics and drug metabolism, including secondary analyses of clinical trial datasets Microbiome studies only with clear evidence of relevance to a precision oncology treatment The journal offers more choice to Nature Portfolio authors who are seeking a fully open-access and more inclusive platform for publishing their work. The journal is led by oncology experts who collaborate to cultivate high-quality research. As part of the npj Series, this journal focuses on fostering global partnerships with the research community and other Springer Nature journals. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Public health. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Internal medicine. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Cancer. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Medical genetics. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Oncology. |
| 9 (RLIN) | 401 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Medical genetics. |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Public Health. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Internal Medicine. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Cancer Biology. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Medical Genetics. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Oncology. |
| 9 (RLIN) | 401 |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Clinical Genetics. |
| 9 (RLIN) | 15929 |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Blakely, Collin M. |
| Relator term | editor. |
| Relator code | edt |
| -- | http://id.loc.gov/vocabulary/relators/edt |
| 9 (RLIN) | 15930 |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kather, Jakob. |
| Relator term | editor. |
| Relator code | edt |
| -- | http://id.loc.gov/vocabulary/relators/edt |
| 9 (RLIN) | 15931 |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bivona, Trever. |
| Relator term | editor. |
| Relator code | edt |
| -- | http://id.loc.gov/vocabulary/relators/edt |
| 9 (RLIN) | 15932 |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dong, Zigang. |
| Relator term | editor. |
| Relator code | edt |
| -- | http://id.loc.gov/vocabulary/relators/edt |
| 9 (RLIN) | 15933 |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bode, Ann M. |
| Relator term | editor. |
| Relator code | edt |
| -- | http://id.loc.gov/vocabulary/relators/edt |
| 9 (RLIN) | 15934 |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Blakely, Collin M. |
| Relator term | editor. |
| Relator code | edt |
| -- | http://id.loc.gov/vocabulary/relators/edt |
| 9 (RLIN) | 15930 |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kather, Jakob. |
| Relator term | editor. |
| Relator code | edt |
| -- | http://id.loc.gov/vocabulary/relators/edt |
| 9 (RLIN) | 15931 |
| 710 2# - ADDED ENTRY--CORPORATE NAME | |
| Corporate name or jurisdiction name as entry element | SpringerLink (Online service) |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1038/41698.2397-768X">https://doi.org/10.1038/41698.2397-768X</a> |
| Public note | Open Access |
Немає доступних примірників.